Np mrd loader

Record Information
Version2.0
Created at2022-09-02 05:21:31 UTC
Updated at2022-09-02 05:21:31 UTC
NP-MRD IDNP0149463
Secondary Accession NumbersNone
Natural Product Identification
Common Name(1s,2r,3s,5s,16e,18e,20r,21s)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2s)-2-(n-methylacetamido)propanoate
DescriptionMAYTANSINE, also known as soravtansine or dmmo-maytansine, belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides. (1s,2r,3s,5s,16e,18e,20r,21s)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2s)-2-(n-methylacetamido)propanoate is found in Gymnosporia diversifolia. (1s,2r,3s,5s,16e,18e,20r,21s)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2s)-2-(n-methylacetamido)propanoate was first documented in 2021 (PMID: 34461087). Based on a literature review a significant number of articles have been published on MAYTANSINE (PMID: 35594923) (PMID: 35373789) (PMID: 35362385) (PMID: 35316825) (PMID: 35161302) (PMID: 35064993).
Structure
Thumb
Synonyms
ValueSource
DMMO-maytansineMeSH
Maytansinoid DM1MeSH
N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansineMeSH
SoravtansineMeSH
DM4, MaytansinoidMeSH
EmtansineMeSH
DM1, MaytansinoidMeSH
MaitansineMeSH
Maytansinoid DM4MeSH
MertansineMeSH
DMMO maytansineMeSH
RavtansineMeSH
Chemical FormulaC34H46ClN3O10
Average Mass692.2000 Da
Monoisotopic Mass691.28717 Da
IUPAC Name(1S,2R,3S,5S,16E,18E,20R,21S)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1^{10,14}.0^{3,5}]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2S)-2-(N-methylacetamido)propanoate
Traditional Name(1S,2R,3S,5S,16E,18E,20R,21S)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1^{10,14}.0^{3,5}]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2S)-2-(N-methylacetamido)propanoate
CAS Registry NumberNot Available
SMILES
CO[C@@H]1\C=C\C=C(C)\CC2=CC(N(C)C(=O)CC(OC(=O)[C@H](C)N(C)C(C)=O)[C@]3(C)O[C@H]3[C@H](C)[C@@H]3C[C@@]1(O)N=C(O)O3)=C(Cl)C(OC)=C2
InChI Identifier
InChI=1S/C34H46ClN3O10/c1-18-11-10-12-26(45-9)34(43)17-25(46-32(42)36-34)19(2)30-33(5,48-30)27(47-31(41)20(3)37(6)21(4)39)16-28(40)38(7)23-14-22(13-18)15-24(44-8)29(23)35/h10-12,14-15,19-20,25-27,30,43H,13,16-17H2,1-9H3,(H,36,42)/b12-10+,18-11+/t19-,20+,25+,26-,27?,30+,33+,34+/m1/s1
InChI KeyWKPWGQKGSOKKOO-QVMUNQMUSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Maytenus diversifoliaLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides.
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassMacrolactams
Sub ClassNot Available
Direct ParentMacrolactams
Alternative Parents
Substituents
  • Macrolactam
  • Alpha-amino acid ester
  • Alanine or derivatives
  • Alpha-amino acid or derivatives
  • Anisole
  • Phenol ether
  • Alkyl aryl ether
  • 1,3-oxazinane
  • Oxazinane
  • Aryl chloride
  • Benzenoid
  • Aryl halide
  • Tertiary carboxylic acid amide
  • Carbamic acid ester
  • Acetamide
  • Carboxylic acid ester
  • Carboxamide group
  • Lactam
  • Alkanolamine
  • Oxacycle
  • Azacycle
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Dialkyl ether
  • Oxirane
  • Ether
  • Monocarboxylic acid or derivatives
  • Carbonyl group
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organochloride
  • Organohalogen compound
  • Organic oxide
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.18ALOGPS
logP3.81ChemAxon
logS-4.8ALOGPS
pKa (Strongest Acidic)3.75ChemAxon
pKa (Strongest Basic)-1.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count10ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area159.96 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity176.94 m³·mol⁻¹ChemAxon
Polarizability70.07 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00002351
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound101529024
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Bai R, Smith AB 3rd, Pettit GR, Hamel E: The interaction of spongistatin 1 with tubulin. Arch Biochem Biophys. 2022 Sep 30;727:109296. doi: 10.1016/j.abb.2022.109296. Epub 2022 May 17. [PubMed:35594923 ]
  2. Eren E, Watts NR, Sackett DL, Wingfield PT: Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action. J Biol Chem. 2021 Oct;297(4):101138. doi: 10.1016/j.jbc.2021.101138. Epub 2021 Aug 28. [PubMed:34461087 ]
  3. Xie HN, Chen YY, Zhu GB, Han HH, Hu XL, Pan ZQ, Zang Y, Xie DH, He XP, Li J, James TD: Targeted delivery of maytansine to liver cancer cells via galactose-modified supramolecular two-dimensional glycomaterial. Chem Commun (Camb). 2022 Apr 19;58(32):5029-5032. doi: 10.1039/d1cc06809a. [PubMed:35373789 ]
  4. Pathak K, Pathak MP, Saikia R, Gogoi U, Sahariah JJ, Zothantluanga JH, Samanta A, Das A: Cancer Chemotherapy via Natural Bioactive Compounds. Curr Drug Discov Technol. 2022;19(4):e310322202888. doi: 10.2174/1570163819666220331095744. [PubMed:35362385 ]
  5. Cheng H, Xiong G, Li Y, Zhu J, Xiong X, Wang Q, Zhang L, Dong H, Zhu C, Liu G, Chen H: Increased yield of AP-3 by inactivation of asm25 in Actinosynnema pretiosum ssp. auranticum ATCC 31565. PLoS One. 2022 Mar 22;17(3):e0265517. doi: 10.1371/journal.pone.0265517. eCollection 2022. [PubMed:35316825 ]
  6. Pitakbut T, Spiteller M, Kayser O: Genome Mining and Gene Expression Reveal Maytansine Biosynthetic Genes from Endophytic Communities Living inside Gymnosporia heterophylla (Eckl. and Zeyh.) Loes. and the Relationship with the Plant Biosynthetic Gene, Friedelin Synthase. Plants (Basel). 2022 Jan 25;11(3):321. doi: 10.3390/plants11030321. [PubMed:35161302 ]
  7. Ma W, Yang Y, Zhu J, Jia W, Zhang T, Liu Z, Chen X, Lin Y: Biomimetic Nanoerythrosome-Coated Aptamer-DNA Tetrahedron/Maytansine Conjugates: pH-Responsive and Targeted Cytotoxicity for HER2-Positive Breast Cancer. Adv Mater. 2022 Nov;34(46):e2109609. doi: 10.1002/adma.202109609. Epub 2022 Feb 17. [PubMed:35064993 ]
  8. Marzullo P, Boiarska Z, Perez-Pena H, Abel AC, Alvarez-Bernad B, Lucena-Agell D, Vasile F, Sironi M, Altmann KH, Prota AE, Diaz JF, Pieraccini S, Passarella D: Maytansinol Derivatives: Side Reactions as a Chance for New Tubulin Binders. Chemistry. 2022 Jan 10;28(2):e202103520. doi: 10.1002/chem.202103520. Epub 2021 Nov 29. [PubMed:34788896 ]
  9. Cho N, Ko S, Shokeen M: Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma. Oncotarget. 2021 Sep 28;12(20):2039-2050. doi: 10.18632/oncotarget.28074. eCollection 2021 Sep 28. [PubMed:34611478 ]
  10. Huang YY, Chen L, Ma GX, Xu XD, Jia XG, Deng FS, Li XJ, Yuan JQ: A Review on Phytochemicals of the Genus Maytenus and Their Bioactive Studies. Molecules. 2021 Jul 28;26(15):4563. doi: 10.3390/molecules26154563. [PubMed:34361712 ]
  11. Kollmannsberger C, Britten CD, Olszanski AJ, Walker JA, Zang W, Willard MD, Radtke DB, Farrington DL, Bell-McGuinn KM, Patnaik A: A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody-drug conjugate, in patients with advanced or metastatic cancer. Invest New Drugs. 2021 Dec;39(6):1613-1623. doi: 10.1007/s10637-021-01146-x. Epub 2021 Jul 15. [PubMed:34264412 ]
  12. Li W, Huang M, Li Y, Xia A, Tan L, Zhang Z, Wang Y, Yang J: C3 ester side chain plays a pivotal role in the antitumor activity of Maytansinoids. Biochem Biophys Res Commun. 2021 Aug 20;566:197-203. doi: 10.1016/j.bbrc.2021.05.071. Epub 2021 Jun 15. [PubMed:34144258 ]
  13. Anderson MG, Zhang Q, Rodriguez LE, Hecquet CM, Donawho CK, Ansell PJ, Reilly EB: ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition. BMC Cancer. 2021 Jun 9;21(1):681. doi: 10.1186/s12885-021-08403-5. [PubMed:34107902 ]
  14. Lombardi J, Lory P, Martin N, Mayeur D, Combret S, Grandvuillemin A, Boulay C, Schmitt A: Trastuzumab-emtansine induced pleural and pericardial effusions. J Oncol Pharm Pract. 2021 Dec;27(8):2041-2044. doi: 10.1177/10781552211015772. Epub 2021 May 18. [PubMed:34000917 ]
  15. Tang SC, Capra CL, Ajebo GH, Meza-Junco J, Mairs S, Craft BS, Zhu X, Maihle N, Hillegass WB: Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer. Int J Cancer. 2021 Apr 12;149(4):909-16. doi: 10.1002/ijc.33597. [PubMed:33844843 ]
  16. LOTUS database [Link]